Gabriel S. Morris - 14 Jul 2022 Form 4 Insider Report for Immix Biopharma, Inc. (IMMX)

Role
CFO, Director
Signature
/s/ Gabriel Morris
Issuer symbol
IMMX
Transactions as of
14 Jul 2022
Net transactions value
$0
Form type
4
Filing time
18 Jul 2022, 06:02:25 UTC
Previous filing
20 Dec 2021
Next filing
15 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMMX Stock Options Award $0 +250,000 +54% $0.000000 716,500 14 Jul 2022 Common Stock 250,000 $2.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options vest monthly in equal amounts over 48 months.